Revenue | ₹2,265.48Cr |
Net Profits | ₹248.14Cr |
Net Profit Margins | 10.95% |
Ipca Laboratories Ltd’s revenue jumped 5.68% since last year same period to ₹2,265.48Cr in the Q3 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated -4.86% fall in its revenue since last 3-months.
Ipca Laboratories Ltd’s net profit jumped 37.95% since last year same period to ₹248.14Cr in the Q3 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 8.13% jump in its net profits since last 3-months.
Ipca Laboratories Ltd’s net profit margin jumped 30.54% since last year same period to 10.95% in the Q3 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 13.65% jump in its net profit margins since last 3-months.
The revenue for Ipca Laboratories Ltd in the Q3 results 2024 was ₹2,265.48Cr.
The net profit for Ipca Laboratories Ltd in the Q3 results 2024 was ₹248.14Cr.
The net profit margin for Ipca Laboratories Ltd in the Q3 results 2024 was 10.95%.
The revenue for Ipca Laboratories Ltd in the Q3 results 2023 was ₹2,143.76Cr.
The net profit for Ipca Laboratories Ltd in the Q3 results 2023 was ₹179.88Cr.
The net profit margin for Ipca Laboratories Ltd in the Q3 results 2023 was 8.39%.